American Century Companies’s AngioDynamics ANGO Stock Holding History

American Century Companies's ANGO Position: Q2 2026 in Review

American Century Companies reduced its AngioDynamics (ANGO) stake by 0.35% in Q2 2026, selling an estimated $3.92K and leaving 98,538 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2336.

American Century Companies first reported a position in ANGO in Q4 2016 and has held it in 26 quarters since. The position peaked at $5.71M in Q3 2017. 129 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

• American Century Companies held 98,538 shares of AngioDynamics worth $1.28M as of Q2 2026.
• American Century Companies sold 344 AngioDynamics shares in Q2 2026, an estimated $3.92K.
• AngioDynamics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2336 holding.
• American Century Companies first reported a position in AngioDynamics in Q4 2016 and has held it in 26 quarters since.
• American Century Companies's AngioDynamics position peaked at $5.71M in Q3 2017.
• 129 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.